Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Davis

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|December 31, 1997
Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5C B Davis, I Dikic, D Unutmaz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to miceT W Hepburn, T K Hart, V L Horton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4A Sharma, C B Davis, L A Tobia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic proteinC B Davis, D J Mitchell, D C Wraith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administrationC B Davis, C S Crysler, V K Boppana, et al.
European Journal of Immunology|March 1, 1992
Disruption of CD8-dependent negative and positive selection of thymocytes is correlated with a decreased association between CD8 and the protein tyrosine kinase, p56lckN S Van Oers, A M Garvin, C B Davis, et al.
Pharmaceutical Research|June 28, 2000
Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapyP Zia-Amirhosseini, R Z Harris, H C Cowley, et al.
Journal of Animal Science|August 16, 2006
Impact of biological and economic variables on optimal parity for replacement in swine breed-to-wean herdsS L Rodriguez-Zas, C B Davis, P N Ellinger, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 29, 1993
CD4 function in thymocyte differentiation and T cell activationN Killeen, C B Davis, K Chu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19C B Davis, T W Hepburn, J J Urbanski, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|December 31, 1997
Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5C B Davis, I Dikic, D Unutmaz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001
Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to miceT W Hepburn, T K Hart, V L Horton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4A Sharma, C B Davis, L A Tobia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic proteinC B Davis, D J Mitchell, D C Wraith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994
Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administrationC B Davis, C S Crysler, V K Boppana, et al.
European Journal of Immunology|March 1, 1992
Disruption of CD8-dependent negative and positive selection of thymocytes is correlated with a decreased association between CD8 and the protein tyrosine kinase, p56lckN S Van Oers, A M Garvin, C B Davis, et al.
Pharmaceutical Research|June 28, 2000
Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapyP Zia-Amirhosseini, R Z Harris, H C Cowley, et al.
Journal of Animal Science|August 16, 2006
Impact of biological and economic variables on optimal parity for replacement in swine breed-to-wean herdsS L Rodriguez-Zas, C B Davis, P N Ellinger, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 29, 1993
CD4 function in thymocyte differentiation and T cell activationN Killeen, C B Davis, K Chu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1995
Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19C B Davis, T W Hepburn, J J Urbanski, et al.
Pageof 6